Predictions
Eramet S.A.
Start price
Target price
Perf. (%)
€142.70
22.03.22
22.03.22
€150.00
22.03.23
22.03.23
-34.27%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Gensight Biologics SA
Start price
Target price
Perf. (%)
€2.97
07.03.22
07.03.22
-
07.03.23
07.03.23
-19.53%
08.03.23
08.03.23
Risky Investment
Vallourec S.A.
Start price
Target price
Perf. (%)
€10.29
07.03.22
07.03.22
-
07.03.23
07.03.23
44.56%
08.03.23
08.03.23
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€2.58
20.02.23
20.02.23
-
20.02.24
20.02.24
-1.16%
05.03.23
05.03.23
Could be very worthwhile Investment >20% year
Ipsos S.A. Inh.
Start price
Target price
Perf. (%)
€51.70
16.11.22
16.11.22
-
16.11.23
16.11.23
17.41%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€328.00
20.02.22
20.02.22
€400.00
20.02.23
20.02.23
1.01%
21.02.23
21.02.23
Could be worthwhile Investment >10% per year
McPhy Energy S.A.
Start price
Target price
Perf. (%)
€13.43
23.10.22
23.10.22
€12.00
23.10.23
23.10.23
-4.21%
18.02.23
18.02.23
Could be worthwhile Investment >10% per year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.87
05.02.23
05.02.23
-
05.02.24
05.02.24
-10.07%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€1.11
01.02.23
01.02.23
-
01.02.24
01.02.24
-0.36%
05.02.23
05.02.23
Risky Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€5.54
01.02.23
01.02.23
-
01.02.24
01.02.24
-48.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Société Générale S.A.
Start price
Target price
Perf. (%)
€23.40
09.03.22
09.03.22
€28.00
09.03.23
09.03.23
14.19%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Société Générale S.A.
Start price
Target price
Perf. (%)
€23.40
09.03.22
09.03.22
€28.00
09.03.23
09.03.23
14.19%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
A.S.T. Groupe S.A.
Start price
Target price
Perf. (%)
€5.84
18.01.22
18.01.22
€8.00
18.01.23
18.01.23
-52.74%
19.01.23
19.01.23
Could be worthwhile Investment >10% per year
LVMH Moët Hennessy Louis Vuitton S.A.
Start price
Target price
Perf. (%)
€714.90
11.01.22
11.01.22
€800.00
11.01.23
11.01.23
6.11%
11.01.23
11.01.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
LVMH Moët Hennessy Louis Vuitton S.A.
Start price
Target price
Perf. (%)
€714.90
11.01.22
11.01.22
€800.00
11.01.23
11.01.23
6.11%
11.01.23
11.01.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
LVMH Moët Hennessy Louis Vuitton S.A.
Start price
Target price
Perf. (%)
€714.90
11.01.22
11.01.22
€800.00
11.01.23
11.01.23
6.11%
11.01.23
11.01.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group